224964-33-4

Upstream product

• 16741-27-8 2,3,4-tri-O-acetyl-α-L-fucopyranosyl bromide 
• 74984-84-2 prop-2-en-1-yl 2-(acetylamino)-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside 
• 572-09-8 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 7512-17-6 N-Acetyl-D-glucosamine 
• 54400-75-8 allyl 2-acetamido-2-deoxy-α-D-glucopyranoside 
• 92420-89-8 methyl 2,3,4-tri-O-acetyl-1-O-(trichloroacetimidoyl)-α-D-glucopyranuronate 
• 108-24-7 acetic anhydride 

Downstream Products

• 251324-19-3 allyl 2-acetamido-3-O-acetyl-4-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 251324-20-6 allyl 2-acetamido-3-O-acetyl-4-O-benzyl-2-deoxy-6-O-tosyl-α-D-glucopyranoside 
• 251324-21-7 allyl 2-acetamido-3-O-acetyl-6-azido-4-O-benzyl-2-deoxy-α-D-glucopyranoside 

Relevant academic research and scientific papers

Side products of glycosidation with selected 2-acetamido-2-deoxy-D-glucopyranosides

Allyl 2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-formyl-α-D-glucopyranoside, N-acetyl-2,3,4-tri-O-acetyl-L-fucopyranosylamine and products of O-acetyl group migration were found as side products during glycosidation of selected 2-acetamido-2-deoxy-D-glucopyranosides.

Synthesis of extended bacterial cell-wall precursor analogues for ligand binding studies with glycopeptide antibiotics

The synthesis of bacterial cell-wall precursor analogues, which resemble the naturally occurring precursor (lipid II) more closely than those hitherto used in NMR binding studies with glycopeptide antibiotics, is reported.